###begin article-title 0
S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Objective
###end title 2
###begin p 3
###xml 280 284 280 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Skp2</sup>
Vascular smooth muscle cell (VSMC) proliferation plays an important role in the development of postangioplasty or in-stent restenosis, venous graft failure, and atherosclerosis. Our previous work has demonstrated S-phase kinase-associated protein-2 (Skp2), an F-box subunit of SCFSkp2 ubiquitin ligase, as an important mediator and common final pathway for growth factors, extracellular matrices, and cyclic-nucleotides to regulate VSMC proliferation in vitro. However, whether alteration of Skp2 function also regulates VSMC proliferation in vivo and neointimal thickening postvascular injury remains unclear. We investigated the effect of Skp2 on VSMC proliferation and neointimal formation in vivo.
###end p 3
###begin title 4
Methods and Results
###end title 4
###begin p 5
###xml 380 384 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 704 708 704 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 327 330 <span type="species:ncbi:10116">rat</span>
###xml 658 661 <span type="species:ncbi:10116">rat</span>
Firstly, we demonstrated that Skp2-null mice developed significantly smaller neointimal areas than wild-type mice after carotid ligation. Secondly, to further identify a local rather than a systemic effect of Skp2 alteration, we demonstrated that adenovirus-mediated expression of dominant-negative Skp2 in the balloon-injured rat carotid artery significantly increased medial p27Kip1 levels, inhibited VSMC proliferation, and the subsequent neointimal thickening. Lastly, to determine if Skp2 alone is sufficient to drive VSMC proliferation and lesion development in vivo, we demonstrated that adenovirus-delivery of wild-type Skp2 to the minimally-injured rat carotids is sufficient to downregulate p27Kip1 protein levels, enhanced medial VSMC proliferation, and the neointimal thickening.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
This data provides, we believe for the first time, a more comprehensive understanding of Skp2 in the regulation of VSMC proliferation and neointimal formation and suggests that Skp2 is a promising target in the treatment of vasculoproliferative diseases.
###end p 7
###begin title 8
Clinical Relevance
###end title 8
###begin p 9
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">skp2</sup>
###xml 549 553 549 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 837 842 <span type="species:ncbi:10090">mouse</span>
###xml 847 850 <span type="species:ncbi:10116">rat</span>
This manuscript describes our latest work investigating the role of the Skp2, an F-box protein component of the SCFskp2 ubiquitin-ligase, in promoting VSMC proliferation, and neointima formation in response to vascular injury in vivo. Our previous work has identified a major role for Skp2 as a key target for numerous positive and negative growth regulatory signals in vitro. These signals converge to regulate the expression of Skp2, which then controls cell-cycle progression by promoting degradation of the cyclin-dependent kinase inhibitor, p27Kip1. Until now, there has been no data in the literature on the role played by Skp2 in the regulation of VSMC proliferation and neointima formation in vivo. Our current manuscript describes, we believe for the first time, the important role played by Skp2 in these processes, using both mouse and rat arterial injury models. This is important because proliferation of VSMCs underlies the development of postangioplasty or post-stenting restenosis, venous graft failure, and transplant arteriosclerosis. Our work demonstrates for the first time that Skp2 is a major regulator of VSMC proliferation and neointimal thickening in vivo in response to vascular injury and highlights Skp2 as a potential target for future strategies designed to combat vasculoproliferative diseases.
###end p 9
###begin p 10
###xml 591 592 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr"><sup>1</sup></xref>
Vascular smooth muscle cell (VSMC) proliferation is rare in normal adult arteries but increases during atherosclerosis. The resulting fibrous cap is vital in protecting the plaque from rupture and subsequent myocardial infarction. On the other hand, excessive VSMC proliferation underlies the development of postangioplasty or post-stenting restenosis, venous graft failure, and transplant arteriosclerosis. Tight regulation of VSMC proliferation is therefore essential. Although a myriad of factors are able to regulate VSMC proliferation, cell-cycle activation is the final common pathway,1 and targeting cell-cycle regulation has emerged as a promising strategy in the treatment of vasculoproliferative diseases.
###end p 10
###begin p 11
###xml 427 431 427 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 436 440 436 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 449 453 449 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip2</sup>
###xml 666 669 666 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,3</sup>
###xml 666 669 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib3" ref-type="bibr"><sup>2,3</sup></xref>
###xml 703 707 703 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Skp2</sup>
###xml 821 822 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr"><sup>4</sup></xref>
###xml 836 840 836 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 841 844 841 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5,6</sup>
###xml 841 844 841 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6" ref-type="bibr"><sup>5,6</sup></xref>
###xml 916 920 916 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 950 953 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7,8</sup>
###xml 950 953 950 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7 bib8" ref-type="bibr"><sup>7,8</sup></xref>
###xml 1104 1108 1104 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1126 1127 1126 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1126 1127 1126 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
Progression through the G1 phase of the cell-cycle is regulated by phosphorylation and inactivation of retinoblastoma (Rb) proteins. This is promoted by the cyclins (cyclin A, D, and E), which associate with and activate the cyclin-dependent kinases (CDK2, CDK4, and CDK6). These CDK:cyclin complexes are subject to negative regulation by the cyclin-dependent kinase inhibitors (CDKIs), such as the Cip/Kip family of CDKIs (p21Cip1, p27Kip1, and p57Kip2). Downregulation of CDKIs during late G1 after addition of growth factors in vitro or balloon injury in vivo is a critical step in allowing activation of cyclin:CDK complexes and subsequent G1/S phase transition.2,3 Skp2 is an F-box component of SCFSkp2 ubiquitin ligase, implicated in the polyubiquitination and proteasomal degradation of many cell-cycle regulators,4 including p27Kip1.5,6 Although many cell-cycle proteins are potential substrates of Skp2, p27Kip1 is considered most important,7,8 because it accumulates in Skp2-null cells and the phenotypic and histologic abnormalities in Skp2-null mice are almost completely reversed in Skp2/p27Kip1 doubly-null mice.8
###end p 11
###begin p 12
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 131 135 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9,10</sup>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib10" ref-type="bibr"><sup>9,10</sup></xref>
###xml 431 435 431 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 520 525 520 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11,12</sup>
###xml 520 525 520 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib12" ref-type="bibr"><sup>11,12</sup></xref>
###xml 747 752 747 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10-12</sup>
###xml 747 752 747 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11 bib12" ref-type="bibr"><sup>10-12</sup></xref>
###xml 1012 1016 1012 1016 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1086 1088 1086 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 1143 1144 1143 1144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1238 1242 1238 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1289 1291 1289 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 1289 1291 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 929 932 <span type="species:ncbi:10116">rat</span>
Increased Skp2 expression along with the related p27Kip1 deregulation has been deemed a marker of poor prognosis in cancer disease.9,10 However, the role of Skp2 in vascular disease is less well established. Our previous work demonstrated that isolated VSMC in culture express high levels of Skp2. Silencing of Skp2 in these cells with siRNA or adenovirus-mediated over-expression of dominant-negative Skp2 (DN-Skp2), increases p27Kip1 levels, and inhibits VSMC proliferation, consistent with an essential role for Skp2.11,12 Moreover, both positive (eg, growth factors and matrix contact) and negative (eg, cyclic-nucleotides) factors for VSMC growth also regulate Skp2 expression in a way reflecting their effects on VSMC proliferation in vitro.10-12 Despite this, evidence that Skp2 regulates VSMC proliferation in vivo remains indirect. For example, we showed that elevation of 3'-5'-cyclic adenosine monophosphate (cAMP) in rat carotid arteries after balloon injury suppresses Skp2 expression, increases p27Kip1 levels, and inhibits both VSMC proliferation and neointima formation.12 Over-expression of a dominant-negative form of the Rac1 GTPase in the same model showed the same association between decreased Skp2 and increased p27Kip1 levels with suppression of VSMC proliferation.13 In the present study, we sought for the first time to provide direct evidence that Skp2 expression regulates VSMC proliferation in vivo sufficiently to affect the final neointimal thickening.
###end p 12
###begin title 13
Materials
###end title 13
###begin p 14
###xml 227 231 227 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 244 248 244 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 213 218 <span type="species:ncbi:10090">Mouse</span>
###xml 325 331 <span type="species:ncbi:9986">Rabbit</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
All reagents, except for those stated otherwise, were purchased from Sigma-Aldrich Co (St. Louis, Mo). Antibodies for Skp2 were obtained from US Biological Inc (Swampscott, Mass) and Invitrogen (Carlsbad, Calif). Mouse anti-p27Kip1 and anti-p21Cip1 antibodies were from BD Transduction Laboratories (Oxford, United Kingdom). Rabbit anti-phospho-Rb and mouse anti-bromodeoxyuridine (BrdU) antibodies were bought from Cell Signaling Technology (Danvers, Mass) and MP Biomedicals (Solon, Ohio), respectively. All secondary antibodies were purchased from Dako (Burlingame, Calif) and NovaRed from Vector Laboratories (Burlingame, Calif).
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10116">rats</span>
Homozygous Skp2-/- and wild type control mice were obtained by crossing heterozygous Skp2+/- mice.7 Genotypes of mice were determined by polymerase change reaction (PCR) of tail tip DNA. Male Sprague-Dawley (SD) rats were obtained from Charles River (Margate, United Kingdom) or BioLASCO Taiwan Co Ltd (Taiwan). The housing and care of the animals and all procedures used adhered to the guidelines and regulations of the United Kingdom Animal (Scientific Procedures) Act 1986, United Kingdom, and Mackay Memorial Hospital, Taiwan.
###end p 17
###begin title 18
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Ligation of mouse common carotid artery
###end title 18
###begin p 19
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Male Skp2-/- and Skp2+/+ mice (20-30 grams) were anesthetized by inhalation of isoflurane and oxygen (0.2 L/minute). The left common carotid artery was ligated near the carotid bifurcation as described.14 All animals were killed 28 days later and perfusion fixed with 4% formaldehyde/phosphate buffered saline (PBS) for 7 minutes before excision of ligated carotid arteries. Vessels were cut into longitudinal sections to increase the accuracy of neointimal area calculation. Sections were stained with Elastic Van Gieson (EVG) and hematoxylin and eosin (H&E) stain and neointimal areas, defined as the area of tissue within the internal elastic lamina, quantified using Image Pro analysis software (MediaCybernetics, Bethesda, Md). Vessel diameter (distance between the external elastic lamellae) and medial thickness (distance between the internal and external elastic lamellae) were measured 300-400 mum distal to the ligation point.
###end p 19
###begin title 20
###xml 18 21 <span type="species:ncbi:10116">rat</span>
Balloon injury of rat common carotid artery
###end title 20
###begin p 21
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
###xml 108 112 <span type="species:ncbi:10116">rats</span>
Balloon injury of left common carotid artery was performed as described by Clowes et al.15 Briefly, male SD rats (approximately400 grams) were anesthetized with an intraperitoneal injection of a mixture of ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg). The bifurcation of the left common carotid artery was surgically exposed, and a 2F arterial embolectomy balloon catheter (Edwards Lifesciences Co, Irvine, Calif) was introduced through an arteriotomy on left external carotid artery. The balloon was inflated with saline and pulled back with rotation through common carotid artery three times. The injured common carotid arteries were then subjected to adenovirus-mediated gene delivery. For cell proliferation assay, animals were injected subcutaneously with BrdU solution (25 mg/kg) at 17, 9, and 1 hour before euthanasia.
###end p 21
###begin title 22
###xml 34 37 <span type="species:ncbi:10116">rat</span>
Filament de-endothelialization of rat common carotid artery
###end title 22
###begin p 23
###xml 139 144 139 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16,17</sup>
###xml 139 144 139 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16 bib17" ref-type="bibr"><sup>16,17</sup></xref>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 153 157 <span type="species:ncbi:10116">rats</span>
The procedures of filament de-endothelialization of rat common carotid artery were modified from the methods developed by MA Reidy's group.16,17 Male SD rats were anesthetized and the left common carotid arteries were approached as described in balloon injury. The endothelium was then denuded from a carotid artery by a 5-0 nylon loop. Briefly, the nylon loop was introduced into the left external carotid artery through a Trocar. The loop was then slowly pulled back along the common carotid artery with constant rotation for approximately30 seconds. The Trocar was retrieved and the artery underwent subsequent adenoviral infection for specific gene expression. Animals were killed and cell proliferation was evaluated as described in the previous section.
###end p 23
###begin title 24
Adenovirus-mediated gene delivery and expression
###end title 24
###begin p 25
###xml 189 191 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 189 191 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 409 410 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 202 205 <span type="species:ncbi:10116">rat</span>
Recombinant replication-defective adenoviruses encoding wild-type Skp2 (Ad:WT-Skp2), dominant-negative Skp2 (Ad:DN-Skp2), and beta-galactosidase (Ad:betaGal) have been described previously.11 To infect rat common carotid artery with adenoviruses for gene expression, both proximal end of common carotid artery and internal carotid artery were temporarily clamped and an aliquot (100 mul) of adenovirus (1 x 109 pfu/mL)/PBS solution was infused into the filament- or balloon-injured common carotid artery through the external carotid artery. Heparin (500 IU/kg) was given intraperitoneally to prevent arterial thrombosis. The adenoviral solution was retained in the vessel for 30 minutes and then withdrawn. After ligation of external carotid artery, the clamps were removed and the blood flow was restored. The infection rate using this protocol was approximately40% of medial smooth muscle cells according to the extent of beta-galactosidase expression (data not shown).
###end p 25
###begin title 26
Immunohistochemical analysis
###end title 26
###begin p 27
###xml 474 478 461 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 483 487 470 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat carotid arteries were perfused fixed in formalin and cut into approximately0.3-cm-long pieces (three pieces per artery) before being embedded in paraffin wax. Each paraffin block containing three pieces of the same carotid artery was cut into 4-mum-thick sections so that each section had three arterial rings representing arterial lesion 0.3 cm apart in the actual artery. For analysis of cell proliferation (BrdU) and cell-cycle regulators (hyperphosphorylated Rb, p27Kip1, p21Cip1, and Skp2), all cells in each arterial ring (approximately300-450 cells per ring) were counted and three arterial rings were analyzed for each carotid artery. The number of positive cells was expressed as a percentage of total cell number calculated by counting hematoxylin counterstained nuclei.
###end p 27
###begin p 28
Cell apoptosis was assessed by terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) method using DNA Fragmentation Kit (Calbiochem) according to the manufacturer's instruction. Briefly, arterial sections were incubated with terminal deoxynucleotidyl transferase (TdT) end-labeling cocktail containing TdT, biotin-dUTP, and TdT buffer. The DNase I (0.375 Kunitz unit/mul) treated arterial rings were served as positive control. The arterial rings were then incubated with fluorescein isothiocyanate (FITC) conjugated avidin. Total cell nuclei visualized by Hoescht 33258 and nuclei containing cleaved DNA (FITC-labeled) cells were counted.
###end p 28
###begin p 29
For the evaluation of neointimal thickening, arterial sections were subjected to H&E staining, followed by neointimal (the tissue within the ring of internal elastic lamina) and medial areas measured using Image Pro software system (MediaCybernetics). The extents of neointimal thickening were presented as intima/media (I/M) ratios.
###end p 29
###begin title 30
Statistical analysis
###end title 30
###begin p 31
###xml 61 62 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 198 199 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All data were expressed as mean +/- SEM. Unpaired two-tailed t test was adopted to test the significance, if appropriate. Where indicated, data was analyzed using nonparametric Mann-Whitney test. A P value less than .05 was considered significant.
###end p 31
###begin title 32
Results
###end title 32
###begin p 33
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 244 246 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 405 406 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 427 428 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 476 481 471 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig 1</xref>
###xml 552 553 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 669 670 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
To demonstrate the overall effect of Skp2 gene deletion on the neointimal thickening, Skp2-/- and Skp2+/+ mice were subjected to common carotid arterial ligation, which induces arterial remodeling, VSMC proliferation, and neointimal thickening.18 Compared with wild-type Skp2 mice (n = 11), Skp2-/- mice (n = 8) developed significantly smaller neointimal areas (130,371 +/- 29,054 vs 52,903 +/- 35,291 mum2; Mann-Whitney test, P = .026) 28 days after common carotid ligation (Fig 1). However, vessel diameter (309.5 +/- 19.5 mum vs 384.8 +/- 40.6 mum, P = .086 for wild-type and Skp2-null, respectively) and medial wall thickness (40.6 +/- 2.1 mum vs 41.0 +/- 2.2 mum, P = .9) was not significantly different between wild-type and Skp2-null mice.
###end p 33
###begin p 34
###xml 654 658 654 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Skp2</sup>
###xml 741 742 741 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr"><sup>5</sup></xref>
###xml 985 989 985 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1054 1055 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1102 1106 1098 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 1171 1172 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1284 1285 1272 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1413 1414 1397 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1568 1573 1549 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig 2</xref>
###xml 1733 1734 1710 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1750 1755 1727 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig 2</xref>
###xml 1823 1842 1800 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec7" ref-type="sec">Fig E1, online only</xref>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 502 505 <span type="species:ncbi:10116">rat</span>
###xml 875 878 <span type="species:ncbi:10116">rat</span>
Further mechanistic studies in the mouse model were impossible because of the small number of longitudinal sections that could be cut from each lesion and the difficulties of breeding additional Skp2-null mice due to low fertility and fecundity. To more specifically elucidate the local effect of Skp2 on VSMC proliferation and neointimal thickening, and to probe more deeply into the mechanisms, we used adenovirus-mediated delivery of either wild-type Skp2 or DN-Skp2 in balloon- or filament-injured rat carotid arteries, respectively. DN-Skp2 is an F-box-deleted Skp2 mutant, which preserves substrate-binding ability but loses its ability to form SCFSkp2 complex, and, therefore, inhibits Skp2 function by competing with endogenous Skp2.5 To test whether local inhibition of Skp2 function also reduces VSMC proliferation in vivo, DN-Skp2 was expressed in balloon-injured rat carotid arteries using an adenoviral vector. The DN-Skp2 expression significantly enhanced medial VSMC p27Kip1 expression (from 15.7 +/- 1.3% to 24.1 +/- 2.5% of medial VSMC, P = .012, n = 6 and 5, respectively) but not p21Cip1 expression (from 20.5 +/- 3.2% to 30.2 +/- 3.9% of medial VSMC, P = .08). DN-Skp2 also inhibited VSMC proliferation measured as BrdU index (from 37.3 +/- 2.5% to 17.0 +/- 3.2%, P < .01, n = 6 and 5, respectively) and hyper-phosphorylation of Rb protein (from 43.5 +/- 4.5% to 25.9 +/- 2.8% of medial VSMC, P = .012), a marker of G1-S phase transition, 4 days after injury, compared with vessels infected with a beta-galactosidase expressing control adenovirus (Fig 2). In addition, subsequent neointimal thickening 14 days postinjury was also significantly reduced by DN-Skp2 (I/M ratios, from 1.58 +/- 0.20 to 0.49 +/- 0.21, P < .01, n = 5) (Fig 2). Importantly, frequency of apoptosis, detected by TUNEL staining (Fig E1, online only), was not increased by expression of dominant-negative Skp2 (less than 0.15% in both Ad: betaGal and Ad:DN-Skp2-infected vessels). This data demonstrates that Skp2 activity is required for maximal VSMC proliferation and neointimal lesion development in vivo.
###end p 34
###begin p 35
###xml 474 479 474 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17,19</sup>
###xml 474 479 474 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib19" ref-type="bibr"><sup>17,19</sup></xref>
###xml 718 719 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 768 772 761 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 810 811 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 858 862 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 900 901 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1013 1014 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1118 1119 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1149 1154 1126 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig 3</xref>
###xml 1343 1344 1313 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1381 1386 1351 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig 4</xref>
We next sought to determine if increased Skp2 activity alone, in the absence of a large medial injury inflicted by balloon angioplasty, can induce VSMC proliferation and neointimal thickening in vivo. To this end, we used adenoviral-delivery of wild-type Skp2 to carotids subjected to filament de-endothelialization. Unlike balloon injury, filament de-endothelialization results in minor medial injury, minimal VSMC proliferation, and thus, a limited thickness of neointima.17,19 Compared with filament-injured carotids infected with control adenovirus (Ad:betaGal), those infected with wild-type Skp2 adenovirus (Ad:WT-Skp2) had substantially increased Skp2 expression (5 +/- 1% compared to 43 +/- 5% of medial VSMC, P < .01), accompanied by reduced expression of p27Kip1 (from 18.4 +/- 5.4% to 0.6 +/- 0.3%, P = .016, n = 4 and 6, respectively) but not p21Cip1 (from 25.8 +/- 4.8 to 18.0 +/- 2.4%, P = .26). Wild-type Skp2 also enhanced VSMC proliferation measured by BrdU incorporation (6 +/- 2% to 32 +/- 5%, P < .01, n = 4 and 6, respectively) and hyper-phosphorylation of Rb (from 9.5 +/- 2.1% to 28.3 +/- 5.5%, P = .015) 4 days after injury (Fig 3). Eight days after filament injury, Ad:WT-Skp2-infected carotids gave rise to significantly higher I/M ratios than those infected with Ad:betaGal (0.11 +/- 0.03 compared to 0.42 +/- 0.09, P = .024, n = 4 and 5, respectively) (Fig 4).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 64 69 64 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20,21</sup>
###xml 64 69 64 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20 bib21" ref-type="bibr"><sup>20,21</sup></xref>
Although the role of Skp2 in the oncogenesis is well recognized,20,21 its role in the regulation of VSMC proliferation is less established. The current studies directly demonstrate for the first time that Skp2 function is involved in injury-induced VSMC proliferation and neointima development in vivo. Furthermore, we demonstrate that Skp2 over-expression is sufficient to drive both proliferation and lesion development after endothelial denudation in the absence of major medial injury. These experiments implicate Skp2 as a novel target for the treatment of vasculoproliferative diseases, such as vascular restenosis after percutaneous vascular intervention.
###end p 37
###begin p 38
###xml 194 199 194 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">22-24</sup>
###xml 194 199 194 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22 bib23 bib24" ref-type="bibr"><sup>22-24</sup></xref>
###xml 346 350 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,25</sup>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib25" ref-type="bibr"><sup>1,25</sup></xref>
###xml 558 563 558 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">26,27</sup>
###xml 558 563 558 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26 bib27" ref-type="bibr"><sup>26,27</sup></xref>
Numerous factors, such as growth factors, inflammatory mediators, extracellular matrix attachment, cell-cell contact, and cyclic nucleotides are involved in the regulation of VSMC proliferation.22-24 Nevertheless, the cell-cycle is the final machinery to integrate and orchestrate intricate upstream signals to delicately tune VSMC proliferation.1,25 Recent encouraging clinical reports show that stents coated with rapamycin or paclitaxel, which target G1-S or G2-M transition, respectively, prevent the occurrence of restenosis after coronary intervention.26,27 This strongly supports the notion that the cell-cycle, the common final pathway for VSMC proliferation, is an ideal target for the treatment of vascular restenosis and, by implication, other vasculoproliferative diseases.
###end p 38
###begin p 39
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 317 322 317 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11,12</sup>
###xml 317 322 317 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib12" ref-type="bibr"><sup>11,12</sup></xref>
###xml 394 399 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11,12</sup>
###xml 394 399 394 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib12" ref-type="bibr"><sup>11,12</sup></xref>
###xml 426 428 426 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28</sup>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr"><sup>28</sup></xref>
###xml 436 437 436 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 635 637 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
Our previous studies established Skp2 as an important mediator in the final common pathway for VSMC proliferation in vitro.10 For example, we showed that positive mediators for VSMC proliferation (growth factors and matrix contact) increase Skp2 levels, whereas negative regulators (cyclic nucleotides) decrease them.11,12 These effects are mediated through regulation of focal adhesion kinase,11,12 phosphoinositide 3-kinase,28 and Rac113 signaling pathways. DN-Skp2 blocks the stimulation of VSMC proliferation after growth factor addition, whereas overexpression of native Skp2 reverses the inhibitory effects of cyclic-nucleotides.12
###end p 39
###begin p 40
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 745 748 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 781 784 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 804 807 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 865 866 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 1128 1129 1128 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1128 1129 1128 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 1192 1195 1192 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1457 1462 1457 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29-31</sup>
###xml 1457 1462 1457 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29 bib30 bib31" ref-type="bibr"><sup>29-31</sup></xref>
###xml 1735 1739 1735 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1808 1813 1808 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32,33</sup>
###xml 1808 1813 1808 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32 bib33" ref-type="bibr"><sup>32,33</sup></xref>
###xml 1951 1955 1951 1955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2000 2004 2000 2004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2112 2116 2112 2116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2184 2186 2184 2186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34</sup>
###xml 2184 2186 2184 2186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr"><sup>34</sup></xref>
###xml 2194 2198 2194 2198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2368 2372 2368 2372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2632 2636 2632 2636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 2704 2708 2704 2708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 2733 2735 2733 2735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28</sup>
###xml 2733 2735 2733 2735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr"><sup>28</sup></xref>
###xml 2748 2752 2748 2752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 2809 2813 2809 2813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2837 2841 2837 2841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 2971 2975 2971 2975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 3008 3010 3008 3010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28</sup>
###xml 3008 3010 3008 3010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr"><sup>28</sup></xref>
###xml 3101 3105 3101 3105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 3476 3479 3476 3479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3582 3586 3582 3586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10116">rats</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
###xml 1606 1609 <span type="species:ncbi:10116">rat</span>
###xml 2204 2208 <span type="species:ncbi:10090">mice</span>
###xml 3480 3484 <span type="species:ncbi:10090">mice</span>
In vivo we also demonstrated that Skp2 expression levels are strikingly enhanced after balloon injury with a time course that perfectly mirrors that of VSMC proliferation.12 Moreover, adventitial application of forskolin (an activator of endogenous cyclic AMP levels) inhibited Skp2 expression, VSMC proliferation, and neointima formation. This indirect evidence supports the role of Skp2 in VSMC proliferation in vivo. Justified by this correlative evidence, we directly tested for the first time whether Skp2 is necessary and sufficient for VSMC proliferation and neointima formation in vivo after vascular injury in mice and rats. Initially, we demonstrated that neointima formation after carotid ligation was significantly attenuated in Skp2-/- mice, compared with that in Skp2+/+ mice. Although Skp2-/- mice tend to be smaller than their wild-type counterparts7 we found that carotid diameter and medial thickness was not different and no gross vessel abnormalities were observed at the time of surgery. Impaired lesion formation in these mice is consistent with previous reports of reduced rates of cellular proliferation.7 It is important to note that impaired lesion formation in Skp2-/- mice could be explained in part by actions of Skp2 in other cells, such as bone marrow progenitor cells, inflammatory cells, fibroblasts, and endothelial cells, all of which may interact with VSMC and contribute significantly to the final neointimal thickening.29-31 To more specifically pinpoint the effects of Skp2 inhibition on local VSMC and neointimal thickening, DN-Skp2 was expressed in balloon-injured rat carotid arteries via adenovirus-mediated gene transfer. The expression of DN-Skp2 resulted in elevated levels of the CDKI p27Kip1, which is normally rapidly downregulated soon after vascular injury.32,33 These observations are consistent with the hypothesis that injury-induced expression of Skp2 is responsible for the downregulation of p27Kip1 after vascular injury. Downregulation of p27Kip1 is thought to be an important step in removing the brake on proliferation, because forced expression of p27Kip1 inhibits S-phase entry and neointima formation after balloon injury34 and p27Kip1-null mice display a hyper-proliferative phenotype and exaggerated responses to vascular injury. We showed here that expression of DN-Skp2 prevented downregulation of p27Kip1 and resulted in significantly reduced levels of hyperphosphorylated Rb protein, a marker of G1-S transition, reduced rates of VSMC proliferation and smaller neointimal lesions. Expression of DN-Skp2 did not, however, significantly effect the expression of p21Cip1, even though our previous data demonstrated that Skp2 regulates p21Cip1 levels in VSMC in vitro.28 However, p21Cip1 regulation seems to be more complicated than that of p27Kip1 in these cells. The p21Cip1 levels actually increase in response to mitogen stimulation, coordinately with increases in Skp2, which functions to maintain p21Cip1 within growth permissive levels.28 This complex pattern of regulation may account for the lack of a significant change in p21Cip1 in this study. Importantly, apoptosis rates were not increased in vessels expressing DN-Skp2, indicating that reduced lesion formation was due to inhibition of proliferation rather than increased cell death. Likewise, expression of DN-Skp2 in VSMC in vitro does not result in increased rate of apoptosis (unpublished data). Taken together with our observations from Skp2-/- mice, our data demonstrates that injury-induced expression of Skp2 is a major mechanism regulating p27Kip1 levels and is essential for VSMC proliferation and the final neointimal thickening.
###end p 40
###begin p 41
###xml 145 147 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 377 379 377 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
###xml 651 655 651 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 779 783 779 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 117 120 <span type="species:ncbi:10116">rat</span>
###xml 429 432 <span type="species:ncbi:10116">rat</span>
We previously demonstrated that exogenous expression of Skp2 is able to force VSMC to enter S-phase in the uninjured rat aorta in organ cultures.11 In the present study, we asked whether increased Skp2 expression would be sufficient to induce VSMC proliferation and neointimal lesion development, in the absence of major medial injury in vivo. Consistent with previous reports,16 we showed that filament de-endothelialization of rat carotid artery caused minimal levels of VSMC proliferation and neointimal thickening, and only a small increase in Skp2 expression. However, forced expression of wild-type Skp2 resulted in a remarkable reduction of p27Kip1 expression and a transmedial increase of BrdU-labeled cells. This demonstrates that Skp2 alone is sufficient to promote p27Kip1 downregulation and VSMC proliferation in the absence of major medial injury.
###end p 41
###begin p 42
###xml 511 515 511 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
Taken together, our data provides the first direct and robust evidence that Skp2 plays an important role in promoting VSMC proliferation and neointimal thickening in vivo in response to vascular injury. These results suggest that Skp2 may represent an attractive target for future gene or pharmacologic-based therapies to combat vasculoproliferative diseases. Targeting Skp2 in this way may be more effective than approaches designed to block the activity of single downstream cell-cycle regulators, such as p27Kip1, because Skp2 regulates the levels and activity of multiple cell-cycle proteins. However, more work is required to elucidate the role and regulation of Skp2 in other vascular cells, particularly endothelial cells, before this may become a reality.
###end p 42
###begin title 43
Author contributions
###end title 43
###begin p 44
###xml 0 29 0 29 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">Conception and design: MB, AN</p>
###xml 0 29 0 29 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">Conception and design: MB, AN</p></list-item>
###xml 29 64 29 64 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">Analysis and interpretation: YW, MB</p>
###xml 29 64 29 64 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">Analysis and interpretation: YW, MB</p></list-item>
###xml 64 108 64 108 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">Data collection: YW, GS, KS, KIN, KN, HY, MB</p>
###xml 64 108 64 108 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">Data collection: YW, GS, KS, KIN, KN, HY, MB</p></list-item>
###xml 108 139 108 139 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">Writing the article: YW, AN, MB</p>
###xml 108 139 108 139 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">Writing the article: YW, AN, MB</p></list-item>
###xml 139 179 139 179 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="49">Critical revision of the article: YW, MB</p>
###xml 139 179 139 179 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="49">Critical revision of the article: YW, MB</p></list-item>
###xml 179 212 179 212 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">Final approval of the article: MB</p>
###xml 179 212 179 212 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">Final approval of the article: MB</p></list-item>
###xml 212 240 212 240 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">Statistical analysis: YW, MB</p>
###xml 212 240 212 240 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">Statistical analysis: YW, MB</p></list-item>
###xml 240 264 240 264 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">Obtained funding: MB, AN</p>
###xml 240 264 240 264 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="52">Obtained funding: MB, AN</p></list-item>
###xml 264 290 264 290 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="53">Overall responsibility: MB</p>
###xml 264 290 264 290 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="53">Overall responsibility: MB</p></list-item>
###xml 0 290 0 290 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><p textid="45">Conception and design: MB, AN</p></list-item><list-item><p textid="46">Analysis and interpretation: YW, MB</p></list-item><list-item><p textid="47">Data collection: YW, GS, KS, KIN, KN, HY, MB</p></list-item><list-item><p textid="48">Writing the article: YW, AN, MB</p></list-item><list-item><p textid="49">Critical revision of the article: YW, MB</p></list-item><list-item><p textid="50">Final approval of the article: MB</p></list-item><list-item><p textid="51">Statistical analysis: YW, MB</p></list-item><list-item><p textid="52">Obtained funding: MB, AN</p></list-item><list-item><p textid="53">Overall responsibility: MB</p></list-item></list>
Conception and design: MB, ANAnalysis and interpretation: YW, MBData collection: YW, GS, KS, KIN, KN, HY, MBWriting the article: YW, AN, MBCritical revision of the article: YW, MBFinal approval of the article: MBStatistical analysis: YW, MBObtained funding: MB, ANOverall responsibility: MB
###end p 44
###begin p 45
Conception and design: MB, AN
###end p 45
###begin p 46
Analysis and interpretation: YW, MB
###end p 46
###begin p 47
Data collection: YW, GS, KS, KIN, KN, HY, MB
###end p 47
###begin p 48
Writing the article: YW, AN, MB
###end p 48
###begin p 49
Critical revision of the article: YW, MB
###end p 49
###begin p 50
Final approval of the article: MB
###end p 50
###begin p 51
Statistical analysis: YW, MB
###end p 51
###begin p 52
Obtained funding: MB, AN
###end p 52
###begin p 53
Overall responsibility: MB
###end p 53
###begin title 54
Appendix
###end title 54
###begin p 55
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Additional material for this article may be found online at</italic>
Additional material for this article may be found online at.
###end p 55
###begin title 56
Supplementary data
###end title 56
###begin p 57
###xml 0 19 0 19 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">Fig E1, online only</title>
###xml 0 19 0 19 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="58">Fig E1, online only</title></caption>
###xml 153 158 150 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig 2</xref>
###xml 19 401 19 398 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">TUNEL analysis of apoptosis in Ad:&#946;Gal and Ad:DN-Skp2 infected rat carotid arteries. Carotid arteries were treated as described in <xref rid="fig2" ref-type="fig">Fig 2</xref>. Apoptotic cell death was analyzed by TUNEL staining of fragmented DNA. DNAse I treated arterial section was used as a positive control for TUNEL staining. TUNEL positive cells are labeled green. Nuclei were counter-stained blue with Hoescht.</p>
###xml 401 401 398 398 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.jpg" mimetype="text" mime-subtype="plain"/>
###xml 0 401 0 398 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="mmc1"><caption><title textid="58">Fig E1, online only</title></caption><p textid="59">TUNEL analysis of apoptosis in Ad:&#946;Gal and Ad:DN-Skp2 infected rat carotid arteries. Carotid arteries were treated as described in <xref rid="fig2" ref-type="fig">Fig 2</xref>. Apoptotic cell death was analyzed by TUNEL staining of fragmented DNA. DNAse I treated arterial section was used as a positive control for TUNEL staining. TUNEL positive cells are labeled green. Nuclei were counter-stained blue with Hoescht.</p><media xlink:href="mmc1.jpg" mimetype="text" mime-subtype="plain"/></supplementary-material>
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Fig E1, online onlyTUNEL analysis of apoptosis in Ad:betaGal and Ad:DN-Skp2 infected rat carotid arteries. Carotid arteries were treated as described in Fig 2. Apoptotic cell death was analyzed by TUNEL staining of fragmented DNA. DNAse I treated arterial section was used as a positive control for TUNEL staining. TUNEL positive cells are labeled green. Nuclei were counter-stained blue with Hoescht.
###end p 57
###begin title 58
Fig E1, online only
###end title 58
###begin p 59
###xml 134 139 131 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig 2</xref>
###xml 66 69 <span type="species:ncbi:10116">rat</span>
TUNEL analysis of apoptosis in Ad:betaGal and Ad:DN-Skp2 infected rat carotid arteries. Carotid arteries were treated as described in Fig 2. Apoptotic cell death was analyzed by TUNEL staining of fragmented DNA. DNAse I treated arterial section was used as a positive control for TUNEL staining. TUNEL positive cells are labeled green. Nuclei were counter-stained blue with Hoescht.
###end p 59
###begin p 60
We thank Dr Raymond C. Bush and Dr Christopher L. Jackson for expert advice and help. We also thank Jill Tarlton for the preparation of adenoviral vectors and Shi-Wei Tseng for the technical help in the experiment.
###end p 60
###begin p 61
The study was supported by the British Heart Foundation, United Kingdom, and National Science Council (grant no. NSC 96-2314-B-195-013-MY3), and Mackay Memorial Hospital (MMH-E-98003), Taiwan.
###end p 61
###begin p 62
Additional material for this article may be found online at .
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies
###end article-title 64
###begin article-title 65
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors
###end article-title 65
###begin article-title 66
Differential effects of the cyclin-dependent kinase inhibitors p27Kip1, p21Cip1, and p16Ink4 on vascular smooth muscle cell proliferation
###end article-title 66
###begin article-title 67
Ubiquitin ligases: cell-cycle control and cancer
###end article-title 67
###begin article-title 68
Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
###end article-title 68
###begin article-title 69
P45Skp2 promotes p27Kip1 degradation and induces S phase in quiescent cells
###end article-title 69
###begin article-title 70
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
###end article-title 70
###begin article-title 71
Skp2-mediated degradation of p27 regulates progression into mitosis
###end article-title 71
###begin article-title 72
Amplification and overexpression of Skp2 are associated with metastasis of non-small-cell lung cancers to lymph nodes
###end article-title 72
###begin article-title 73
Beyond oncogenesis: The role of s-phase kinase-associated protein-2 (skp2) in vascular restenosis
###end article-title 73
###begin article-title 74
Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (skp-2) stability
###end article-title 74
###begin article-title 75
Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation
###end article-title 75
###begin article-title 76
Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo
###end article-title 76
###begin article-title 77
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow
###end article-title 77
###begin article-title 78
Kinetics of cellular proliferation after arterial injury
###end article-title 78
###begin article-title 79
Regrowth of arterial endothelium
###end article-title 79
###begin article-title 80
###xml 28 31 <span type="species:ncbi:10116">rat</span>
Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury
###end article-title 80
###begin article-title 81
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model
###end article-title 81
###begin article-title 82
Role of basic fibroblast growth factor in vascular lesion formation
###end article-title 82
###begin article-title 83
###xml 39 44 <span type="species:ncbi:9606">human</span>
Skp2 is oncogenic and overexpressed in human cancers
###end article-title 83
###begin article-title 84
###xml 55 60 <span type="species:ncbi:9606">human</span>
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
###end article-title 84
###begin article-title 85
Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies
###end article-title 85
###begin article-title 86
Role of metalloproteinases in plaque rupture
###end article-title 86
###begin article-title 87
R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation
###end article-title 87
###begin article-title 88
Cell cycle progression: new therapeutic target for vascular proliferative disease
###end article-title 88
###begin article-title 89
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
###end article-title 89
###begin article-title 90
A paclitaxel-eluting stent for the prevention of coronary restenosis
###end article-title 90
###begin article-title 91
Biphasic effect of p21Cip1 on smooth muscle cell proliferation: Role of PI 3-kinase and Skp2-mediated degradation
###end article-title 91
###begin article-title 92
Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries
###end article-title 92
###begin article-title 93
Inflammation, atherosclerosis, and coronary artery disease
###end article-title 93
###begin article-title 94
Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?
###end article-title 94
###begin article-title 95
Expression of cyclin-dependent kinase inhibitors in vascular disease
###end article-title 95
###begin article-title 96
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin
###end article-title 96
###begin article-title 97
###xml 171 174 <span type="species:ncbi:10116">rat</span>
Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27Kip1, an inhibitor of neointima formation in the rat carotid artery
###end article-title 97
###begin p 98
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 79 82 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arrows</italic>
###xml 279 280 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
Neointimal thickening 28 days after common carotid ligation in Skp2+/+ and Skp2-/- mice. Carotid ligation was performed on wild-type or homozygous Skp2-null mice. A, Representative longitudinal sections of from both groups 28 days post-ligation. Arrows locate ligation position. B, Quantification of neointimal areas. The comparison was made using Mann-Whitney test.
###end p 98
###begin p 99
###xml 24 28 24 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 305 306 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 451 452 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 526 530 522 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 553 557 549 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 669 675 664 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arrows</italic>
###xml 700 701 695 696 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 821 822 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 842 843 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 108 111 <span type="species:ncbi:10116">rat</span>
###xml 153 156 <span type="species:ncbi:10116">rat</span>
DN-Skp2 up regulates p27Kip1 levels, inhibits VSMC proliferation and neointima formation in balloon-injured rat common carotid arteries. Balloon-injured rat common carotid arteries were infected with either Ad:betaGal (control) or Ad:DN-Skp2 by the luminal retention of 100 mul adenoviral solution (1 x 109 pfu/mL) for 30 minutes. The animals were injected with BrdU (25 mg/kg) at 17, 9, and 1 hour before euthanasia on the day 4 post balloon-injury. A, Representative pictures of arterial sections undergoing staining for p27Kip1, BrdU, phospho-Rb, p21Cip1, 4 days post injury and hematoxylin and eosin staining 14 days post injury, as indicated. Scale bars = 50 mum. Arrows indicate labeled cells. B, Quantified results of the immunohistochemistry and I/M ratios. Data are expressed as % of labeled cells. ** indicates P < .01, * indicates P < .02.
###end p 99
###begin p 100
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 231 232 228 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 368 372 365 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 389 393 386 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 553 559 547 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 679 685 672 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arrows</italic>
###xml 710 711 703 704 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 825 826 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 846 847 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 105 108 <span type="species:ncbi:10116">rat</span>
Skp2 over expression down regulates p27Kip1 levels and increases VSMC proliferation in minimally-injured rat common carotid arteries. After filament de-endothelialization, carotid arteries were infected with Ad:betaGal or Ad:Skp2. A, Representative pictures of both groups. Carotid arterial sections were subjected to immunohistochemistry for the staining of Skp2, p27Kip1, phospho-Rb, p21Cip1 and BrdU 4 days post infection. Of note, Skp2- and BrdU-labeled cells were detected in Ad:betaGal infected vessels mostly over the superficial layer of media (arrows), whereas those infected with Ad:Skp2 tended to have Skp2 and BrdU-positive cells trans-medially. Scale bars = 50 mum. Arrows indicate labeled cells. B, Quantification of the immunohistochemistry. Data are expressed as the percentage of labeled cells. ** indicates P < .01, * indicates P < .02.
###end p 100
###begin p 101
###xml 125 130 125 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig 4</xref>
###xml 286 291 286 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig 2</xref>
###xml 293 294 293 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 357 358 356 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Wild-type Skp2 enhances neointimal thickening in minimally-injured rat carotid arteries. Carotid arteries were treated as in Fig 4. Eight days after filament de-endothelialization, the carotids from both treatment groups were subjected to hematoxylin and eosin staining as described in Fig 2. A, Representative pictures of both groups. Scale bar = 100 mum. B, Quantified results of I/M ratios.
###end p 101

